ArticleEuropean journal of clinical pharmacology2012

Metabolism of alprazolam (a marker of CYP3A4) in hemodialysis patients with persistent inflammation.

Hadi Molanaei et al.PubMed ↗Publisher ↗

No numbers read from the abstract.